Dermatology is the specialized branch of medicine focusing on the skin and treatment of skin related diseases and conditions. This includes a variety of conditions, both pathological and cosmetic.
A dermatologist is a doctor, who through several years of post medical school training, specializes in the treatment of skin, hair, and nails. The diagnosis, treatment, and prevention of skin cancers, melanomas, moles, and other skin tumors are some of the most common focuses of a dermatologist.
Other conditions commonly treated are acne, rashes (such as psoriasis and lichen planus), impetigo, herpes zoster, syphilis, and fungal diseases (i.e. athletes foot).
In addition to treating pathological skin conditions, dermatologists have become leaders in the field of cosmetic surgery. Some of the procedures frequently performed by cosmetic dermatologists include, but are not limited to; botox injections, collagen treatments, liposuction, laser skin therapies (for hair removal, skin resurfacing, tattoo removal, etc), and varicose vein removal.
All reports in Dermatology
|
Medicated Skin Care in the US
4/3/2012 | published by: Euromonitor International
... retail growth of 4% in 2011. Nappy (diaper) rash treatments also continued to grow – leaping 7% in current value terms in 2011 – as budget-minded parents overextend the time their children are spending in ...
|
more...
|
$900.00
|
|
Medicated Skin Care in Argentina
3/26/2012 | published by: Euromonitor International
... is one of the main attributes linked to the attractiveness of a woman. However, 63% believe that their hair does not have enough nutrients and vitamins. Furthermore, unlike what happens in other parts of the ...
|
more...
|
$900.00
|
|
Alopecia – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Alopecia. 'Alopecia - Pipeline Review, H1 2012' is built using data and information ...
|
more...
|
$500.00
|
|
Rosacea – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Rosacea. 'Rosacea - Pipeline Review, H1 2012' is built using data and information ...
|
more...
|
$500.00
|
|
Skin Rash – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Skin rash, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin rash. 'Skin rash - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Hand Dermatitis – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Hand Dermatitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hand Dermatitis. 'Hand Dermatitis - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Dermatitis – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dermatitis. 'Dermatitis - Pipeline Review, H1 2012' is built using data and information ...
|
more...
|
$500.00
|
|
Medicated Skin Care in Denmark
3/13/2012 | published by: Euromonitor International
... Some consumers are time-constrained whilst others might feel embarrassed about their particular skin condition. Vaginal antifungals, hair loss treatments, antiparasitics/lice (head and body) treatments and cold sore treatments are skin conditions that most sufferers... Euromonitor ...
|
more...
|
$900.00
|
|
Botulinum Toxin
3/1/2012 | published by: Global Industry Analysts
... World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.The report profiles 22 companies including many key and niche players such as ...
|
more...
|
$4,500.00
|
|
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
3/1/2012 | published by: Kalorama Information
... that may help to shape the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and acquisitions in the industry, ...
|
more...
|
$3,995.00
|
|
Atopic Dermatitis (Eczema) – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... the therapeutic development for Atopic Dermatitis (Eczema), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Atopic Dermatitis (Eczema). 'Atopic Dermatitis ...
|
more...
|
$500.00
|
|
Acne And Related Disorders – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Acne And Related Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne ...
|
more...
|
$500.00
|
|
Acne Vulgaris – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Acne Vulgaris, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne Vulgaris. 'Acne Vulgaris - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Analytical Tool - Melanoma
2/21/2012 | published by: BioSeeker Group AB
... research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. ...
|
more...
|
$4,650.00
|
|
Dermatological Drugs: World Market Prospects 2012-2022
1/18/2012 | published by: Visiongain
... submarket, product and national levels to 2022. How will 24 leading drugs - Valtrex, Zovirax, Protopic, Enbrel and others - perform from 2012? Our report gives you business research and analysis with many sales forecasts. ...
|
more...
|
$2,642.00
|
|
Dermatological Drugs: World Market Prospects 2012-2022
1/18/2012 | published by: Visiongain
... submarket, product and national levels to 2022. How will 24 leading drugs - Valtrex, Zovirax, Protopic, Enbrel and others - perform from 2012? Our report gives you business research and analysis with many sales forecasts. ...
|
more...
|
$2,642.00
|
|
Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline
1/6/2012 | published by: GBI Research
... research, “Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline”. It provides in-depth analysis of the unmet needs, drivers and barriers ...
|
more...
|
$3,500.00
|
|
Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials
1/1/2012 | published by: GBI Research
... - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials’ which provides an insight into different endpoints that are used in dermatological clinical trials. The ...
|
more...
|
$3,500.00
|
|
Dermatitis Global Clinical Trials Review, H2, 2011
12/19/2011 | published by: GlobalData
... to the clinical trials on Dermatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ...
|
more...
|
$1,000.00
|
|
Dermatologists - Industry Market Research Report
12/1/2011 | published by: IBISWorld
... small establishments, and dermatologists are competing with lower-cost providers of similar services, such as medical spas. In response, dermatologists are progressively focusing on subspecialties, such as cosmetic dermatology or dermapathology. Costs are also on the ...
|
more...
|
$910.00
|
|
Wrinkles - Pipeline Review, H2 2011
11/28/2011 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Wrinkles. 'Wrinkles - Pipeline Review, H2 2011' is built using data and information ...
|
more...
|
$500.00
|
|
Acne Vulgaris Global Clinical Trials Review, H2, 2011
11/11/2011 | published by: GlobalData
... and data relating to the clinical trials on Acne Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...
|
more...
|
$1,000.00
|
|
Acne Treatment Manufacturing OTC - Industry Market Research Report
11/3/2011 | published by: IBISWorld
... as disposable incomes improve and manufacturers cater to consumer preferences for all-natural products. Nevertheless, competition from prescription acne treatments and laser procedures may limit overall growth. This industry manufactures over-the-counter (i.e. non-prescription) acne treatment and ...
|
more...
|
$910.00
|
|
Indian Aesthetic (Cosmetic) Surgery Market: 2011 Edition
11/1/2011 | published by: Koncept Analytics
... all the passion to look young and beautiful coupled with willingness to spend on cosmetic procedures. The medical industry in India is supporting the growth of the cosmetic surgery market with its well equipped and ...
|
more...
|
$800.00
|
|
China Dermatitis Prescription Drug Sales Data 2006-2010
11/1/2011 | published by: Draco Healthcare Consulting LLC
... and drug purchasing data from extensive hospital coverage in 16 major cities and more than 300 hospitals. Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, ...
|
more...
|
$8,000.00
|
